Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial by Berge, E, Cohen, G, Roaldsen, M, Lundström, E, Isaksson, E, Rudberg, A, Slot, K, Forbes, J, Smith, J, Drever, J, Wardlaw, J, Lindley, R, Sandercock, P, Whiteley, W

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3])... by Sandercock, P, Wardlaw, J, Lindley, R, Dennis, M, Cohen, G, Murray, G, Innes, K, Venables, G, Czlonkowska, A, Kobayashi, A, Ricci, S, Murray, V, Berge, E, Slot, K, Hankey, G, Correia, M, Peeters, A, Matz, K, Lyrer, P, Gubitz, G, Phillips, S, Arauz, A